Liver stiffness test to predict liver problems in MAFLD
Part of Digestive system, Hormones & metabolism clinical trials.
This study uses a special ultrasound device called iLivTouch to measure liver stiffness. It aims to see if changes in liver stiffness over time can predict serious liver problems in people with metabolic fatty liver disease. If you have MAFLD and your liver is already stiff, this could help doctors monitor your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a condition called MAFLD (fatty liver disease related to metabolism) that has reached an advanced stage, as shown by a liver stiffness measurement of at least 10 kPa.
- You need to have at least two valid liver stiffness measurements taken at least 12 months apart.
- You must not have other liver diseases like hepatitis (viral infection), drug-induced liver injury, or autoimmune liver disease.
- You must not drink more than 210 grams of alcohol per week (men) or 140 grams per week (women).
- You must not have had certain liver procedures, liver cancer, or other major health issues recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of liver scanners that measure liver stiffness (a sign of scarring) to see if a new handheld device works as well as the standard one. If the devices are similar, it may allow easier and more affordable liver monitoring for people with chronic liver disease.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
This study uses a special ultrasound technique, called shear wave elastography, to measure liver stiffness during an endoscopic ultrasound (EUS) procedure. It aims to see how well this new method detects liver scarring (fibrosis) in people with fatty liver disease, compared to standard tests like FibroScan and liver biopsy.
This study tests whether a new scoring method can help doctors identify liver inflammation in patients who have both type 2 diabetes and a fatty liver. The goal is to find an easier, safer way to assess liver health without invasive procedures.
This study checks if a simple blood test (LIVERFASt) can accurately measure liver fat and scarring compared to MRI. It may help patients avoid more invasive tests in the future.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.